Abstract
To clarify possible roles of DCC expression in tumour differentiation and cell kinetics, we immunohistochemically investigated 80 uterine cervical adenocarcinomas (C-ACs), including 31 mucinous (M) and 31 endometrioid (E) lesions, and 18 adenocarcinomas in situ (AIS), along with 39 normal cervical samples. The results were compared with findings for p21WAF1/Cip1 and p27Kip1 expression, apoptosis, cell proliferation and human papillomavirus (HPV) infection. Nine C-AC cases were also examined using a combination of the reverse transcription-polymerase chain reaction and Southern blot hybridization, as well as Western blot assays. Significantly decreased DCC scores were observed in E-ACs but not M-ACs, as compared to normal cervical glandular epithelia and AIS. Average p21WAF1/Cip1 and p27Kip1 scores were significantly higher in E-ACs than M-ACs, in line with high apoptotic, mitotic and Ki-67 labelling indices. A concordance of the results for DCC and p21WAF1/Cip1 expression between mRNA- and protein-based assays was also noted. Change of DCC expression, however, was not related to any of the cell kinetic markers or clinicopathological features in ACs of either type. There was also no association with the HPV status, although infection was significantly linked with high values for cell kinetics. These results suggest that DCC expression in C-ACs is closely associated with mucinous differentiation.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Coates, P. J., d’Ardenne, A. J., Khan, G., Kangro, H. O. & Slavin, G. (1991) Simplified procedures for applying the polymerase chain reaction to routinely fixed paraffin wax sections. J Clin Pathol 44: 115–118.
Dyson, N., Howley, P. M., Munger, K. & Harlow, E. (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 3812–3815.
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzier, K. W. & Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
Enomoto, T., Fujita, M., Cheng, C., Nakashima, R., Ozaki, M., Inoue, M. & Nomura, T. (1995) Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Br J Cancer 71: 462–467.
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W. & Vogelstein, B. (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247: 49–56.
Gao, X., Honn, K. V., Grignon, D., Sakr, W. & Chen, Y. Q. (1993) Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res 53: 2723–2727.
Gima, T., Kato, H., Honda, T., Imamura, T., Sasazuki, T. & Wake, N. (1994) DCC gene alteration in human endometrial carcinomas. Int J Cancer 57: 480–485.
Ginsberg, D., Mechta, F., Yaniv, M. & Oren, M. (1991) Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci USA 88: 9979–9983.
Goi, T., Yamaguchi, A., Nakagawara, G., Urano, T., Shiku, H. & Furukawa, K. (1998) Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers. Br J Cancer 77: 466–471.
Hannon, G. J. & Beach, D. (1994) p15INK4B is a potent effector of TGF-β-induced cell cycle arrest. Nature 371: 257–261.
Harper, J. W., Adami, G. R., Wei, N., Keyomarski, K. & Elledge, S. J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805–816.
Hedrick, L., Cho, K. R., Fearon, E. R., Wu, T-C, Kinzler, K. W. & Vogelstein, B. (1994) The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev 8: 1174–1183.
Huang, Y., Boynton, R. F., Blount, P. L., Silverstein, R. J., Yin, J., Tong, Y., McDaniel, T. K., Newkirk, C., Resau, J. H., Sridhara, R., Reid, B. J. & Meltzer, S. J. (1992) Loss of heterozygosity involves multiple tumour suppressor genes in human esophageal cancers. Cancer Res 52: 6525–6530.
Jordan, R. C. K., Bradley, G. & Slingerland, J. (1998) Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity. Am J Pathol 152: 585–590.
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harsham, K., Tavtigian, S. V., Stockert, E., Day, R. S., III Johnson, B. E. & Scholinck, M. H. A. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436–440.
Kerr, J. F. R., Winterford, C. M. & Harmon, B. V. (1994) Apoptosis: its significance in cancer and cancer therapy. Cancer 73: 2013–2026.
Kikuchi-Yanoshita, R., Konishi, M., Fukunari, H., Tanaka, K. & Miyaki, M. (1992) Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 52: 3801–3803.
Klingelhutz, A. J., Hedrick, L., Cho, K. R. & McDougall, J. K. (1995) The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 10: 1581–1586.
Kong, X-T, Choi, S. H., Inoue, A., Xu, F., Chen, T., Takita, J., Yolota, J., Bessho, F., Yanagisawa, M., Hanada, R., Yamamoto, K. & Hayashi, Y. (1997) Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma. Cancer Res 57: 3772–3778.
Koshida, Y., Saegusa, M. & Okayasu, I. (1997) Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinicopathological study. Br J Cancer 75: 367–373.
Mercer, W. E., Shields, M. T., Lin, D., Appella, E. & Ullrich, S. J. (1991) Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc Natl Acad Sci USA 88: 1958–1962.
Nadal, A., Jares, P., Cazorla, M., Fernandez, P. L., Sar Juan, X., Hernandez, L., Pinyol, M., Aldea, M., Mallofre, C., Muntane, J., Traserra, J., Campo, E. & Cardesa, A. (1997) p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx. J Pathol 183: 156–163.
Narayanan, R., Lawlor, R. Q. J., Schaapveld, K. R., Cho, K. R., Vogelstein, B., Tran, P. B. V., Osborne, M. P. & Telang, N. T. (1992) Antisense RNA to the putative tumor suppressor gene DCC transforms Rat-1 fibroblasts. Oncogene 7: 553–561.
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K. & Carson, D. A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753–756.
Park, D. J., Wilczynski, S. P., Paquette, R. L., Miller, C. W. & Koeffler, H. P. (1994) p53 mutations in HPV-negative cervical carcinoma. Oncogene 9: 205–210.
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M. & Koff, A. (1994) p21KIP1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8: 9–22.
Reale, M. A., Hu, G., Zafar, A. I., Getzenberg, R. H., Levine, S. M. & Fearon, E. R. (1994) Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res 54: 4493–4501.
Saegusa, M., Takano, Y., Hashimura, M., Shoji, Y. & Okayasu, I. (1995) The possible role of bcl-2 expression in the progression of tumors of the ureine cervix. Cancer 76: 2297–2303.
Saegusa, M., Kamata, Y., Isono, M. & Okayasu, I. (1996) Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas. J Pathol 180: 275–282.
Serrano, M., Hannon, G. J. & Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704–707.
Sgambato, A., Zhang, Y-J, Arber, N., Hibshoosh, H., Doki, Y., Ciaparrone, M., Santella, R. M., Cittadini, A. & Weinstein, I. B. (1997) Deregulated expression of p27Kip1 in human breast cancers. Clin Cancer Res 3: 1879–1887.
Toh, Y., Kuwano, H., Tanaka, S., Baba, K., Matsuda, H., Sugimachi, K. & Mori, R. (1992) Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer 70: 2234–2238.
Toyoshima, H. & Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67–74.
Uchino, S., Tsuda, H., Noguchi, M., Yokota, J., Terada, M., Saito, T., Kobayashi, M., Sugimura, T. & Hirohashi, S. (1992) Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 52: 3099–3102.
Werness, B. A., Levine, A. J. & Howley, P. M. (1990) Association of human papillomavirus types 16 and 18 E^ proteins with p53. Science 248: 76–79.
Yasui, W., Akama, Y., Kuniyasu, H., Yokozaki, H., Semba, S., Shimamoto, F. & Tahara, E. (1996) Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity. J Pathol 180: 122–128.
Yasui, W., Kudo, Y., Semba, S., Yokozaki, H. & Tahara, E. (1997) Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res 88: 625–629.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Saegusa, M., Okayasu, I. DCC expression is related to mucinous differentiation but not changes in expression of p21WAF1/Cip1 and p27Kip1, apoptosis, cell proliferation and human papillomavirus infection in uterine cervical adenocarcinomas. Br J Cancer 80, 51–58 (1999). https://doi.org/10.1038/sj.bjc.6690320
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690320